Department of Medicine Archive — Page 88 of 120
-
May 3, 2018
LEAP Fellowship bolsters Staub’s antimicrobial stewardship research
Infectious Disease fellow Milner Staub, MD, is among the first awardees of the Leadership in Epidemiology, Antimicrobial Stewardship, and Public health (LEAP) Fellowship. -
April 26, 2018
Ware elected VP of clinical investigation society
With last week’s election of Lorraine Ware, MD, as vice president of the American Society for Clinical Investigation (ASCI), two faculty members of the Vanderbilt University School of Medicine are among the current officers of the elite physician-scientist honor society. -
April 19, 2018
Former FDA official explores big data’s impact on healthcare
“Big data” can help reverse the alarming decline in life expectancy in the United States — if universities and academic medical centers take the lead, former U.S. Food and Drug Administrator Robert Califf, MD, told a Vanderbilt audience last week. -
April 19, 2018
Symposium to honor Robertson’s research contributions
David Robertson, MD, internationally known for his groundbreaking work in defining and treating often-debilitating neurological disorders of blood pressure regulation, will be honored with a two-day symposium May 3-4 at Langford Auditorium. -
April 12, 2018
Initiative stresses importance of advance directives
While many might prefer to not think about dying, healthcare professionals throughout the United States are encouraging patients and their families to do just that during a national awareness campaign April 16-22 that promotes the importance of completing an advance directive for healthcare. -
April 12, 2018
Alpha-gal found to be both a medication and red meat allergy
Alpha-gal allergy has commonly been referred to as “the red meat” allergy, but doctors at the Vanderbilt Asthma, Sinus and Allergy Program (ASAP) helped uncover that not only red meat, but some medications, can contain alpha-gal. -
April 10, 2018
Vanderbilt scientists test potential new way to treat anemia
Treatment of anemia caused by chronic kidney disease or other diseases often requires repeated — and costly — injections or infusions of an artificial form of the hormone erythropoietin (EPO), which stimulates production of red blood cells.